New Results

SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is further increased by a naturally occurring elongation variant

Yoriyuki Konno, Izumi Kimura, Keiya Uriu, Masaya Fukushi, Takashi Irie, Yoshio Koyanagi, So Nakagawa, Kei Sato
doi: https://doi.org/10.1101/2020.05.11.088179

Article usage

Article usage: May 2020 to February 2025

AbstractFullPdf
May 2020170086864304
Jun 202033342541295
Jul 202042982631044
Aug 20205077380982
Sep 2020133299481
Oct 202081248227
Nov 202059730161
Dec 202046040121
Jan 202160639123
Feb 20215493695
Mar 20215444198
Apr 20213581767
May 20213182063
Jun 20213252070
Jul 20214481246
Aug 2021302740
Sep 2021161842
Oct 2021177628
Nov 2021142929
Dec 2021144514
Jan 2022108219
Feb 2022114920
Mar 2022126413
Apr 202291118
May 202271518
Jun 2022123420
Jul 2022143416
Aug 2022148214
Sep 2022113312
Oct 202289120
Nov 202213957
Dec 2022139617
Jan 20231241217
Feb 2023130537
Mar 2023133849
Apr 2023104613
May 202375712
Jun 20237937
Jul 202395610
Aug 2023148117
Sep 2023160310
Oct 2023140628
Nov 2023831710
Dec 2023888037
Jan 2024816102
Feb 2024621173
Mar 202477219
Apr 2024108722
May 202478254
Jun 202483811
Jul 202457513
Aug 20243668
Sep 2024791215
Oct 2024941058
Nov 202486917
Dec 20245267
Jan 202564119
Feb 2025824
Back to top
Posted May 12, 2020.
Download PDF

Supplementary Material

Email
SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is further increased by a naturally occurring elongation variant
Yoriyuki Konno, Izumi Kimura, Keiya Uriu, Masaya Fukushi, Takashi Irie, Yoshio Koyanagi, So Nakagawa, Kei Sato
bioRxiv 2020.05.11.088179; doi: https://doi.org/10.1101/2020.05.11.088179
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area